Lebrikizumab Withdrawn Phase 3 Trials for Asthma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02546869A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting